Research Article
Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer
Table 1
The correlation between STMN1 expression and clinical characteristics in patients with ovarian cancer.
| Clinical parameters | Low STMN1 expression () | High STMN1 expression () | value |
| Age (years) | | | | ≤60 | 19 | 20 | 0.105 | >60 | 4 | 12 | | Pathological classification | | | | Serous cystadenocarcinoma | 14 | 26 | 0.389 | Mucinous cystadenocarcinoma | 4 | 3 | | Clear cell carcinoma | 4 | 2 | | Endometrioid carcinoma | 1 | 1 | | FIGO staging | | | | I-II | 12 | 6 | 0.009 | III-IV | 11 | 26 | | Tumor differentiation | | | | G1 | 9 | 2 | 0.001 | G2-G3 | 10 | 28 | | Tumor size | | | | ≤5 cm | 4 | 9 | 0.355 | >5 cm | 19 | 23 | | Lymph node metastasis | | | | Yes | 3 | 12 | 0.094 | No | 12 | 14 | | CA125 level | | | | ≤500 U/mL | 17 | 19 | 0.263 | >500 U/mL | 6 | 13 | |
|
|
Notes: . Abbreviations: FIGO: International Federation of Gynecology and Obstetrics; CA125: carbohydrate antigen 125. |